Skip to search formSkip to main contentSkip to account menu

Cytogen 356

Known as: CYT 356, CYT-356 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Stored serum from clinical trial cases undergoing ProstaScint® (CYT‐356) scanning were available for Prostate Specific Membrane… 
Highly Cited
1996
Highly Cited
1996
  • N. Deb, M. Goris, S. Knox
  • Clinical cancer research : an official journal of…
  • 1996
  • Corpus ID: 23105335
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… 
Highly Cited
1996
Highly Cited
1996
The utility of monoclonal antibody (MAb) imaging for detection of occult recurrent prostate cancer was investigated in 14… 
Highly Cited
1994
Highly Cited
1991
Highly Cited
1991
A phase 1 study was conducted with the investigational immunoscintigraphic agent, 111In‐CYT‐356, a radiolabeled, site‐specific… 
Highly Cited
1990
Highly Cited
1990
In this study, a site-specific immunoconjugate, designated CYT-356, of the prostate-reactive monoclonal antibody 7E11-C5 was…